FI954082A0 - Sappisuolan stimuloiman lipaasin muunnoksia, niitä koodaavat DNA-molekyylit ja siirtogeenisiä nisäkkäitä, jotka eivät ole ole ihmisiä - Google Patents

Sappisuolan stimuloiman lipaasin muunnoksia, niitä koodaavat DNA-molekyylit ja siirtogeenisiä nisäkkäitä, jotka eivät ole ole ihmisiä

Info

Publication number
FI954082A0
FI954082A0 FI954082A FI954082A FI954082A0 FI 954082 A0 FI954082 A0 FI 954082A0 FI 954082 A FI954082 A FI 954082A FI 954082 A FI954082 A FI 954082A FI 954082 A0 FI954082 A0 FI 954082A0
Authority
FI
Finland
Prior art keywords
bssl
bile salt
modifications
dna molecules
stimulated lipase
Prior art date
Application number
FI954082A
Other languages
English (en)
Swedish (sv)
Other versions
FI954082A (fi
Inventor
Lars Blaeckberg
Michael Edlund
Lennart Hansson
Olle Hernell
Lennart Lundberg
Mats Stroemqvist
Jan Toernell
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9300686A external-priority patent/SE9300686D0/xx
Priority claimed from SE9300722A external-priority patent/SE9300722D0/xx
Application filed by Astra Ab filed Critical Astra Ab
Publication of FI954082A0 publication Critical patent/FI954082A0/fi
Publication of FI954082A publication Critical patent/FI954082A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A01K67/0278—Knock-in vertebrates, e.g. humanised vertebrates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/20—Dietetic milk products not covered by groups A23C9/12 - A23C9/18
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18—Carboxylic ester hydrolases (3.1.1)
    • C12N9/20—Triglyceride splitting, e.g. by means of lipase
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2207/00—Modified animals
    • A01K2207/15—Humanized animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/01—Animal expressing industrially exogenous proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20041—Use of virus, viral particle or viral elements as a vector
    • C12N2710/20043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
    • C12N2830/002—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination inducible enhancer/promoter combination, e.g. hypoxia, iron, transcription factor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/008—Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/80—Vector systems having a special element relevant for transcription from vertebrates
    • C12N2830/85—Vector systems having a special element relevant for transcription from vertebrates mammalian

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Food Science & Technology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Environmental Sciences (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Virology (AREA)
  • Animal Husbandry (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Hematology (AREA)
  • Pulmonology (AREA)
FI954082A 1993-03-01 1995-08-31 Sappisuolan stimuloiman lipaasin muunnoksia, niitä koodaavat DNA-molekyylit ja siirtogeenisiä nisäkkäitä, jotka eivät ole ole ihmisiä FI954082A (fi)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9300686A SE9300686D0 (sv) 1993-03-01 1993-03-01 Novel polypeptides
SE9300722A SE9300722D0 (sv) 1993-03-04 1993-03-04 Novel polypeptides ii
PCT/SE1994/000160 WO1994020610A1 (en) 1993-03-01 1994-02-25 Variants of bile salt-stimulated lipase, dna molecules encoding them, and transgenic non-human mammals

Publications (2)

Publication Number Publication Date
FI954082A0 true FI954082A0 (fi) 1995-08-31
FI954082A FI954082A (fi) 1995-08-31

Family

ID=26661673

Family Applications (1)

Application Number Title Priority Date Filing Date
FI954082A FI954082A (fi) 1993-03-01 1995-08-31 Sappisuolan stimuloiman lipaasin muunnoksia, niitä koodaavat DNA-molekyylit ja siirtogeenisiä nisäkkäitä, jotka eivät ole ole ihmisiä

Country Status (28)

Country Link
US (2) US5827683A (fi)
EP (1) EP0687296B1 (fi)
JP (1) JP3837444B2 (fi)
KR (2) KR100312825B1 (fi)
CN (2) CN1071790C (fi)
AT (1) ATE317429T1 (fi)
AU (1) AU675701B2 (fi)
BR (1) BR9406376A (fi)
CA (1) CA2156083C (fi)
CZ (1) CZ290927B6 (fi)
DE (1) DE69434622T2 (fi)
DK (1) DK0687296T3 (fi)
EE (1) EE9400458A (fi)
ES (1) ES2258262T3 (fi)
FI (1) FI954082A (fi)
HU (1) HU221119B1 (fi)
IL (2) IL144015A (fi)
IS (1) IS4130A (fi)
NO (1) NO953426L (fi)
NZ (1) NZ262529A (fi)
PL (1) PL184960B1 (fi)
PT (1) PT687296E (fi)
RU (1) RU2219239C2 (fi)
SG (1) SG52597A1 (fi)
SK (1) SK285420B6 (fi)
TW (1) TW387013B (fi)
UA (1) UA48109C2 (fi)
WO (1) WO1994020610A1 (fi)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5696087A (en) * 1994-12-01 1997-12-09 Oklahoma Medical Research Foundation Method and compositions for reducing cholesterol absorption
US5821226A (en) * 1994-12-01 1998-10-13 Oklahoma Medical Research Foundation BAL C-tail drug delivery molecules
CA2206526A1 (en) * 1994-12-01 1996-06-06 Oklahoma Medical Research Foundation Method and compositions for reducing cholesterol absorption
US5681819A (en) * 1994-12-01 1997-10-28 Oklahoma Medical Research Foundation Method and compositions for reducing cholesterol absorption
FR2733249B1 (fr) * 1995-04-20 1997-06-06 Biocem Lipase gastrique de chien recombinante et polypeptides derives produits par les plantes, leurs procedes d'obtention et leurs utilisations
SE9501939D0 (sv) * 1995-05-24 1995-05-24 Astra Ab DNA molecules for expression of polypeptides
US6342218B1 (en) 1997-02-14 2002-01-29 Oklahoma Medical Research Foundation Method for treatment of SLE
SE9801424D0 (sv) * 1998-04-22 1998-04-22 Astra Ab Expression methods
AU2001255469A1 (en) * 2000-04-21 2001-11-07 Monsanto Technology Llc Purification of ace inhibiting polypeptides containing vpp from milk
CA2558754C (fr) 2004-03-31 2015-09-22 Universite De La Mediterranee Glycopeptides derives de structures pancreatiques, anticorps et leurs applications en diagnostic et therapeutique
FR2868424B1 (fr) * 2004-03-31 2008-04-11 Univ Aix Marseille Ii Glycopeptides derives de structures pancreatiques, anticorps et leurs applications en diagnostic et therapeutique
CN100343391C (zh) * 2004-12-31 2007-10-17 中国农业大学 卵巢注射法制备转基因动物
EP2039764A1 (en) * 2007-09-19 2009-03-25 Pevion Biotech AG Truncated secretory aspartyl proteinase 2
EP2629789A1 (en) 2010-10-21 2013-08-28 Swedish Orphan Biovitrum AB (Publ) Method to increase the absorption of unsaturated fatty acids by human infants
JP5850940B2 (ja) * 2010-10-21 2016-02-03 スウェディッシュ オーファン バイオビトラム パブリーク アクチエボラグ ヒト乳児の発育速度を増大させる方法
FR2966734B1 (fr) 2010-10-29 2014-07-18 Max Rombi Composition comprenant au moins une enzyme proteolytique pour son utilisation pour empecher la synthese des triglycerides
WO2012158109A1 (en) * 2011-05-18 2012-11-22 Swedish Orphan Biovitrum Ab (Publ) Low ph protein purification process
CN103088000A (zh) * 2012-03-23 2013-05-08 北京济福霖生物技术有限公司 在哺乳动物乳腺中过表达胆盐激活脂酶的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4944944A (en) * 1987-11-19 1990-07-31 Oklahoma Medical Research Foundation Dietary compositions and methods using bile salt-activated lipase
US5200183A (en) * 1987-11-19 1993-04-06 Oklahoma Medical Research Foundation Recombinant bile salt activated lipases
SE9001985D0 (sv) * 1990-06-01 1990-06-01 Astra Ab New chemical products

Also Published As

Publication number Publication date
EP0687296A1 (en) 1995-12-20
CN1071790C (zh) 2001-09-26
IL108698A0 (en) 1994-05-30
SG52597A1 (en) 1998-09-28
CZ216995A3 (en) 1997-05-14
PL310413A1 (en) 1995-12-11
CA2156083C (en) 2008-07-15
IL144015A (en) 2006-08-20
US5763739A (en) 1998-06-09
HU9502561D0 (en) 1995-10-30
DE69434622T2 (de) 2006-08-24
NO953426D0 (no) 1995-08-31
ES2258262T3 (es) 2006-08-16
EP0687296B1 (en) 2006-02-08
US5827683A (en) 1998-10-27
SK108595A3 (en) 1997-01-08
CN1346888A (zh) 2002-05-01
HU221119B1 (en) 2002-08-28
IS4130A (is) 1994-09-02
HUT73398A (en) 1996-07-29
JPH08507439A (ja) 1996-08-13
RU2219239C2 (ru) 2003-12-20
NZ262529A (en) 1997-07-27
ATE317429T1 (de) 2006-02-15
CZ290927B6 (cs) 2002-11-13
AU6223794A (en) 1994-09-26
CA2156083A1 (en) 1994-09-15
PT687296E (pt) 2006-05-31
EE9400458A (et) 1996-06-17
CN1187450C (zh) 2005-02-02
DE69434622D1 (de) 2006-04-20
WO1994020610A1 (en) 1994-09-15
BR9406376A (pt) 1996-01-16
AU675701B2 (en) 1997-02-13
NO953426L (no) 1995-08-31
KR100357016B1 (ko) 2002-10-19
JP3837444B2 (ja) 2006-10-25
FI954082A (fi) 1995-08-31
CN1121355A (zh) 1996-04-24
PL184960B1 (pl) 2003-01-31
UA48109C2 (uk) 2002-08-15
TW387013B (en) 2000-04-11
SK285420B6 (sk) 2007-01-04
KR100312825B1 (ko) 2001-12-28
DK0687296T3 (da) 2006-06-12

Similar Documents

Publication Publication Date Title
FI954082A0 (fi) Sappisuolan stimuloiman lipaasin muunnoksia, niitä koodaavat DNA-molekyylit ja siirtogeenisiä nisäkkäitä, jotka eivät ole ole ihmisiä
ATE317904T1 (de) Überexpression von phytase in hefesystemen
DE69316501D1 (de) Proteasen zur Inhibierung und Beseitigung von Biofilm
FI960469A0 (fi) DNA:ta sekvenssoivia entsyymejä
ATE290086T1 (de) Herstellung von phytat-degradierenden enzymen in trichoderma
PT584446E (pt) Proteina de transferencia de trigliceridos microssomicos
HUP9801638A2 (hu) Kevésbé adszorbeálódó és jobban hidrolizáló proteáz K variánsok
WO2000006718A3 (en) Expression of functional eukaryotic proteins
DE59712469D1 (en) Invertase-inhibitor
DE69838810D1 (de) Gen von alteromonas
WO1998005760A3 (en) Phosphate starvation-inducible proteins
FR2681076B1 (fr) Adn recombinant codant pour une proteine a activite endochitinase.
DE69934017D1 (de) 2,6-beta-d-fruktanhydrolase enzym und verfahren zu dessen verwendung
WO1999055883A3 (en) Triacylglycerol lipases
ATE239082T1 (de) Dna, welche für eine chitin-synthase aus arthropoden kodiert
IT8621735A0 (it) Microorganiscmi manipolati con mezzi di ingegneria genetica per la produzione di l-amminoacidi.
FR2685919B1 (fr) Proteine a activite de type cytokine, adn recombinant codant pour cette proteine, cellules animales transformees.
WO2001018190A3 (de) Dihydroorotase aus pflanzen
AU1825900A (en) Polypeptides having choline oxidase activity and nucleic acids encoding same

Legal Events

Date Code Title Description
MA Patent expired